Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5977)
All Articles published online
|
Jul 7, 2010 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Berasain C, Goñi S, Castillo J, Latasa MU, Prieto J, Ávila MA. Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences. World J Gastroenterol 2010; 16(25): 3091-3102 [PMID: 20593494 DOI: 10.3748/wjg.v16.i25.3091] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i25/3091.htm |
| Number | Citing Articles |
| 1 |
Yu-Liang Lee, Jie-Wei Weng, Wen-Chin Chiang, Yi-Wen Lin, Ka-Lok Ng, Jeffrey Jing-Pha Tsai, Chi-Ying Huang. Investigating Cancer-related Proteins Specific Domain Interactions and Differential Protein Interactions Caused by Alternative Splicing. 2011 IEEE 11th International Conference on Bioinformatics and Bioengineering 2011; : 33 doi: 10.1109/BIBE.2011.12
|
| 2 |
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster. Alternative RNA Splicing in Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.613213
|
| 3 |
João Paulo Tavanez, Rafael Caetano, Cristina Branco, Inês Margarida Brito, Ana Miragaia‐Pereira, Tatiana Vassilevskaia, Ana Sofia Quina, Celso Cunha. Hepatitis delta virus interacts with splicing factor SF3B155 and alters pre‐mRNA splicing of cell cycle control genes. The FEBS Journal 2020; 287(17): 3719 doi: 10.1111/febs.15352
|
| 4 |
Yifan Li, Qiaozhen Zhu, Shuchang Zhou, Jiangtao Chen, Aoyu Du, Changjiang Qin. Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1202732
|
| 5 |
A. Fassina. ‘The map is not the territory’: FNA the map and liver the territory. Cytopathology 2011; 22(5): 285 doi: 10.1111/j.1365-2303.2011.00928.x
|
| 6 |
Meraris Soto, Maria Reviejo, Ruba Al-Abdulla, Marta R. Romero, Rocio I.R. Macias, Loreto Boix, Jordi Bruix, Maria A. Serrano, Jose J.G. Marin. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(5): 165687 doi: 10.1016/j.bbadis.2020.165687
|
| 7 |
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
|
| 8 |
Yufeng Li, Junyu Xu, Yuting Lu, Hua Bian, Lin Yang, Honghong Wu, Xinwen Zhang, Beilei Zhang, Maoqian Xiong, Yafei Chang, Jie Tang, Fan Yang, Lei Zhao, Jing Li, Xin Gao, Mingfeng Xia, Minjia Tan, Jingya Li. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. Cell Metabolism 2021; 33(10): 2004 doi: 10.1016/j.cmet.2021.09.008
|
| 9 |
Jiayou Wang, Noah Kainrad, Hong Shen, Zhou Zhou, Paula Rote, Yanqiao Zhang, Laura E. Nagy, Jiashin Wu, Min You. Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice. The American Journal of Pathology 2018; 188(8): 1807 doi: 10.1016/j.ajpath.2018.05.004
|
| 10 |
Olga Krivtsova, Anna Makarova, Natalia Lazarevich. Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma. World Journal of Hepatology 2018; 10(10): 645-661 doi: 10.4254/wjh.v10.i10.645
|
| 11 |
Carmen Berasain, Maria Arechederra, Josepmaria Argemí, Maite G. Fernández-Barrena, Matías A. Avila. Loss of liver function in chronic liver disease: An identity crisis. Journal of Hepatology 2023; 78(2): 401 doi: 10.1016/j.jhep.2022.09.001
|
| 12 |
Lu Zhang, Xiaoqiao Liu, Xuegong Zhang, Ronghua Chen. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets. Molecular Genetics and Genomics 2016; 291(3): 1035 doi: 10.1007/s00438-015-1163-y
|
| 13 |
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
|
| 14 |
Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Dominique Wendum, Audrey Clapéron, Yves Chrétien, Colette Rey, Olivier Scatton, Olivier Soubrane, Filomena Conti, Françoise Praz, Chantal Housset, Olivier Rosmorduc, Christèle Desbois-Mouthon. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors. Cancer Research 2013; 73(13): 3974 doi: 10.1158/0008-5472.CAN-12-3824
|
| 15 |
Hualin Wang, Bouchra Lekbaby, Nadim Fares, Jeremy Augustin, Tarik Attout, Aurelie Schnuriger, Anne-Marie Cassard, Ganna Panasyuk, Gabriel Perlemuter, Ivan Bieche, Sophie Vacher, Janick Selves, Jean-Marie Péron, Brigitte Bancel, Philippe Merle, Dina Kremsdorf, Janet Hall, Isabelle Chemin, Patrick Soussan. Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcome. Hepatology International 2019; 13(4): 454 doi: 10.1007/s12072-019-09950-7
|
| 16 |
Carla Rojo, María Gárate-Rascón, Miriam Recalde, Ane Álava, María Elizalde, María Azkona, Iratxe Aldabe, Elisabet Guruceaga, Amaya López-Pascual, M Ujue Latasa, Bruno Sangro, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis. JHEP Reports 2024; 6(8): 101118 doi: 10.1016/j.jhepr.2024.101118
|
| 17 |
Clémence Pinel, Barbara Prainsack, Christopher McKevitt. Markers as mediators: A review and synthesis of epigenetics literature. BioSocieties 2018; 13(1): 276 doi: 10.1057/s41292-017-0068-x
|
| 18 |
Julio Gutiérrez, Karel H. M. van Wely, Carlos Martínez-A. Hepatitis, testicular degeneration, and ataxia in DIDO3-deficient mice with altered mRNA processing. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00804-8
|
| 19 |
Masaaki Takamura, Satoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, Yutaka Aoyagi. Involvement of liver-intestine cadherin in cancer progression. Medical Molecular Morphology 2013; 46(1): 1 doi: 10.1007/s00795-012-0003-y
|
| 20 |
María Elizalde, Raquel Urtasun, María Azkona, María U. Latasa, Saioa Goñi, Oihane García-Irigoyen, Iker Uriarte, Victor Segura, María Collantes, Mariana Di Scala, Amaia Lujambio, Jesús Prieto, Matías A. Ávila, Carmen Berasain. Splicing regulator SLU7 is essential for maintaining liver homeostasis. Journal of Clinical Investigation 2014; 124(7): 2909 doi: 10.1172/JCI74382
|
| 21 |
Nicholas J. G. Webster. Alternative RNA Splicing in the Pathogenesis of Liver Disease. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00133
|
| 22 |
Hao Peng, Yifan Yang, Shandian Zhe, Jian Wang, Michael Gribskov, Yuan Qi, Alfonso Valencia. DEIsoM: a hierarchical Bayesian model for identifying differentially expressed isoforms using biological replicates. Bioinformatics 2017; 33(19): 3018 doi: 10.1093/bioinformatics/btx357
|
| 23 |
Huang Li, Zhijia Wang, Xuexia Zhou, Yuanming Cheng, Zhiqin Xie, James L. Manley, Ying Feng. Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression. Proceedings of the National Academy of Sciences 2013; 110(29) doi: 10.1073/pnas.1310607110
|
| 24 |
Gui-Qi Zhu, Yu-Jie Zhou, Li-Xin Qiu, Biao Wang, Yi Yang, Wei-Ting Liao, Yi-Hong Luo, Ying-Hong Shi, Jian Zhou, Jia Fan, Zhi Dai. Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data. Carcinogenesis 2019; doi: 10.1093/carcin/bgz073
|
| 25 |
Shu Ly Lim, Carmela Ricciardelli, Martin K. Oehler, Izza M. D. De Arao Tan, Darryl Russell, Frank Grützner, Rajeev Samant. Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer. PLoS ONE 2014; 9(6): e99687 doi: 10.1371/journal.pone.0099687
|
| 26 |
Carmen Berasain, Matías A. Avila. Regulation of hepatocyte identity and quiescence. Cellular and Molecular Life Sciences 2015; 72(20): 3831 doi: 10.1007/s00018-015-1970-7
|
| 27 |
Belinda J. Petri, Kellianne M. Piell, Banrida Wahlang, Kimberly Z. Head, Eric C. Rouchka, Juw Won Park, Jae Yeon Hwang, Mayukh Banerjee, Matthew C. Cave, Carolyn M. Klinge. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease. Environmental Toxicology and Pharmacology 2023; 103: 104260 doi: 10.1016/j.etap.2023.104260
|
| 28 |
María Gárate-Rascón, Miriam Recalde, Carla Rojo, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease. International Journal of Molecular Sciences 2022; 23(21): 13411 doi: 10.3390/ijms232113411
|
| 29 |
Carmen Berasain, María Elizalde, Raquel Urtasun, Josefa Castillo, Oihane García-Irigoyen, Iker Uriarte, Maria U Latasa, Jesús Prieto, Matías A Avila. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis. Hepatic Oncology 2014; 1(2): 241 doi: 10.2217/hep.13.17
|
| 30 |
Marie-Pier Tremblay, Victoria E. S. Armero, Andréa Allaire, Simon Boudreault, Camille Martenon-Brodeur, Mathieu Durand, Elvy Lapointe, Philippe Thibault, Maude Tremblay-Létourneau, Jean-Pierre Perreault, Michelle S. Scott, Martin Bisaillon. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. BMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-3029-z
|
| 31 |
Anjali Kashyap, Greesham Tripathi, Avantika Tripathi, Rashmi Rao, Manju Kashyap, Anjali Bhat, Deepak Kumar, Anjali Rajhans, Pravindra Kumar, Darshan Shimoga Chandrashekar, Riaz Mahmood, Amjad Husain, Hatem Zayed, Alok Chandra Bharti, Manoj Kumar Kashyap. RNA splicing: a dual-edged sword for hepatocellular carcinoma. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01726-8
|
| 32 |
Maria Reviejo, Meraris Soto, Elisa Lozano, Maitane Asensio, Olga Martínez-Augustin, Fermín Sánchez de Medina, Jose J.G. Marin. Impact of alternative splicing on mechanisms of resistance to anticancer drugs. Biochemical Pharmacology 2021; 193: 114810 doi: 10.1016/j.bcp.2021.114810
|
| 33 |
Maria Gargani, Alessio Valentini, Lorraine Pariset. A novel point mutation within the EDA gene causes an exon dropping in mature RNA in Holstein Friesian cattle breed affected by X-linked anhidrotic ectodermal dysplasia. BMC Veterinary Research 2011; 7(1): 35 doi: 10.1186/1746-6148-7-35
|
| 34 |
Yoshito Tomimaru, Chelsea Q. Xu, Sarah B. Nambotin, Tao Yan, Jack R. Wands, Miran Kim. Loss of exon 4 in a human T‐cell factor‐4 isoform promotes hepatic tumourigenicity. Liver International 2013; 33(10): 1536 doi: 10.1111/liv.12189
|
| 35 |
Tatsuhiro Shibata, Hiroyuki Aburatani. Exploration of liver cancer genomes. Nature Reviews Gastroenterology & Hepatology 2014; 11(6): 340 doi: 10.1038/nrgastro.2014.6
|
| 36 |
Jose J. G. Marin, Maria Reviejo, Meraris Soto, Elisa Lozano, Maitane Asensio, Sara Ortiz-Rivero, Carmen Berasain, Matias A. Avila, Elisa Herraez. Impact of Alternative Splicing Variants on Liver Cancer Biology. Cancers 2021; 14(1): 18 doi: 10.3390/cancers14010018
|